← FDA DRUG APPROVALS

FDA ANDA · ANDA090700

VERAPAMIL HYDROCHLORIDE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA090700
TYPE
ANDA
ORIGINAL APPROVAL
2011-08-03
LATEST ACTION
2021-12-22
ROUTE
ORAL
DOSAGE FORM
TABLET, EXTENDED RELEASE
MARKETING STATUS
Prescription

Products

VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 120MG · TABLET, EXTENDED RELEASE · ORAL
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 180MG · TABLET, EXTENDED RELEASE · ORAL

Approval history

2021-12-22Labeling · Supplement 7 · standardAP
2019-09-26Labeling · Supplement 6 · standardAP
2019-09-26Labeling · Supplement 4 · standardAP
2015-04-09Labeling · Supplement 2 · standardAP
2015-04-09Labeling · Supplement 3 · standardAP
2011-08-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →